Free Trial

Owens & Minor, Inc. (NYSE:OMI) Shares Acquired by Algert Global LLC

Owens & Minor logo with Medical background

Algert Global LLC boosted its position in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 71.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,516 shares of the company's stock after purchasing an additional 39,947 shares during the period. Algert Global LLC owned about 0.12% of Owens & Minor worth $1,289,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Riverview Trust Co purchased a new stake in shares of Owens & Minor in the first quarter valued at about $25,000. Hexagon Capital Partners LLC lifted its stake in Owens & Minor by 1,240.2% in the 1st quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company's stock valued at $43,000 after buying an additional 1,451 shares in the last quarter. GAMMA Investing LLC grew its holdings in Owens & Minor by 52.1% during the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company's stock valued at $46,000 after buying an additional 563 shares during the last quarter. Quarry LP increased its position in Owens & Minor by 38.8% during the fourth quarter. Quarry LP now owns 2,573 shares of the company's stock worth $50,000 after buying an additional 719 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of Owens & Minor by 43,142.9% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,027 shares of the company's stock worth $84,000 after acquiring an additional 3,020 shares during the last quarter. 98.04% of the stock is owned by institutional investors and hedge funds.

Owens & Minor Trading Up 0.7 %

Shares of OMI stock traded up $0.10 on Friday, reaching $14.68. 379,436 shares of the stock were exchanged, compared to its average volume of 837,006. Owens & Minor, Inc. has a 1-year low of $12.36 and a 1-year high of $28.35. The stock has a market cap of $1.12 billion, a P/E ratio of -29.04, a price-to-earnings-growth ratio of 0.49 and a beta of 0.39. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.17. The firm has a 50 day moving average of $15.50 and a two-hundred day moving average of $18.27.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings results on Friday, August 2nd. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.33 by $0.03. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The company had revenue of $2.67 billion during the quarter, compared to analyst estimates of $2.65 billion. During the same period in the prior year, the firm posted $0.18 earnings per share. The firm's revenue was up 4.2% on a year-over-year basis. On average, research analysts anticipate that Owens & Minor, Inc. will post 1.57 EPS for the current year.

Analyst Ratings Changes

A number of analysts recently commented on OMI shares. Citigroup raised Owens & Minor from a "neutral" rating to a "buy" rating and decreased their price objective for the company from $24.00 to $19.00 in a research note on Friday, July 19th. Robert W. Baird cut their price objective on shares of Owens & Minor from $20.00 to $19.00 and set a "neutral" rating for the company in a research report on Tuesday, July 16th. Bank of America decreased their target price on shares of Owens & Minor from $18.00 to $16.00 and set an "underperform" rating on the stock in a research report on Tuesday, June 25th. JPMorgan Chase & Co. cut their price target on Owens & Minor from $22.00 to $18.00 and set an "underweight" rating for the company in a report on Wednesday, August 21st. Finally, Barclays decreased their price objective on Owens & Minor from $23.00 to $18.00 and set an "equal weight" rating on the stock in a report on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Owens & Minor presently has a consensus rating of "Hold" and an average target price of $20.00.

Read Our Latest Report on OMI

About Owens & Minor

(Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Read More

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Should you invest $1,000 in Owens & Minor right now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom’s Momentum Returns: Will It Reach New Highs?
Toyota’s Big Bet on Joby: Will Air Taxis Revolutionize Travel by 2025?
UnitedHealth Group: A Healthcare Giant with Strong Dividends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines